Table 5 of
Querques, Mol Vis 2014; 20:575-592. Table 5 of
Querques, Mol Vis 2014; 20:575-592.
Table 5. Changes in mean measurements and in specific features in patients with Best vitelliform macular dystrophy reverting or not from vitelliruptive stage to pseudohypopyon stage.
| Vitelliruptive to pseudohypopyon (n=3) FU: 53.0±25.5 months | Study entry | Last visit | P value |
|---|---|---|---|
| BCVA (LogMAR) | 0.2±0.1 | 0.2±0.1 | - |
| Overall lesion area (mm2) | 4.57±2.7 | 5.36±3.0 | 0.1 |
| Hyperautofluorescent component of the lesion (mm2) | 0 | 1.87±1.5 | 0.01 |
| Hypoautofluorescent component of the lesion (mm2) | 4.57±2.7 | 3.49±1.3 | 0.03 |
| FAF fovea (n) | Hypo=3 | Hypo=3 | - |
| EZ status fovea (n) | Disrupted=3 | Disrupted=3 | |
| OCT reflectivity (n) | Hypo=3 | Mixed=3 | - |
| Maximal OCT lesion thickness (μm) | 285.2±44.2 | 291.5±51.6 | 0.1 |
| Maximal OCT lesion width (μm) | 2289.2±382.1 | 2329.5±457.5 | 0.3 |
| OCT neurosensory retinal thickness fovea (μm) | 92.4±4.3 | 89.0±5.6 | 0.1 |
| CMT (μm) | 397.2±61.4 | 417.0±52.3 | 0.1 |
| Vitelliruptive not progressing to pseudohypopyon (n=5) FU: 52.8±4.6months | Study entry | Last visit | P value |
| BCVA (LogMAR) | 0.28±0.2 | 0.26±0.2 | - |
| Overall lesion area (mm2) | 5.15±4.0 | 5.5±4.0 | 0.1 |
| Hyperautofluorescent component of the lesion (mm2) | 0 | 0 | - |
| Hypoautofluorescent component of the lesion (mm2) | 5.15±4.0 | 5.5±4.0 | 0.1 |
| FAF fovea (n) | Hypo=5 | Hypo=5 | - |
| EZ status fovea (n) | Disrupted=5 | Disrupted=5 | |
| OCT reflectivity (n) | Mixed=5 | Mixed=5 | - |
| Maximal OCT lesion thickness (μm) | 233.6±99.6 | 188.8±120.4 | 0.02 |
| Maximal OCT lesion width (μm) | 2283.0±822.6 | 1818.8±592.0 | 0.07 |
| OCT neurosensory retinal thickness fovea (μm) | 105.2±50.9 | 81.2±19.4 | 0.04 |
| CMT (μm) | 361.4±52.2 | 365.6±33.9 | 0.8 |